Search Results

1 - 9 of 9 items :

  • Central Europe x
  • Gastroenterology x
Clear All
Rapidly Progressive Glomerulonephritides, Diagnostic and Therapeutic Urgency

.R. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med. 2009;150:670–680. (PubMed) 9. Hilhorst M., Wilde B., van Paassen P. Improved outcome in anti-neutrophil cytoplasmic antibody (ANCA)- associated glomerulonephritis: a 30-year follow-up study. Nephrol Dial Transplant. 2013;28:373–379. (PubMed) 10. Robson J., Doll H., Suppiah R. Damage in the ANCAassociated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic

Open access
The Dilemma in Treatment of hemodialysis patients with catheter-induced right atrial thrombi (CRAT): A case report

REFERENCES 1. HUSSAIN N, SHATTUCK P.E., SENUSSI M.H., et al. , Large right atrial thrombus associated with central venous catheter requiring open heart surgery . Case Rep Med 2012; 2012:501303. 2. SHAH A., MURRAY M., NZERUE C. M., Right atrial thrombi complicating use of central venous catheters in hemodialysis . International Journal of Artificial Organs 2004; 27 (9):772-8. 3. STAVROULOPOULOS A., ARESTI V., ZOUNIS C., Right atrial thrombi complicating haemodialysis catheters. A meta-analysis of reported cases and a proposal of a management

Open access
Profile of hepatocellular carcinoma in the Republic of Moldova: first-hand information on the presentation, distribution and etiologies

hepatitis in Central Europe . J Viral Hepat. 2009; 16 :883-94. 25. WEDEMEYER H. and MANNS, M. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead . Nat Rev Gastroenterol Hepatol. 2010; 7 :31-40. 26. WRANKE A., PINHEIRO BORZACOV, L., PARANA, R., LOBATO, C., HAMID, S., CEAUSU, E., et al. Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN) . Liver Int. 2017; 38 :842-50. 27. NEGRO F. Hepatitis D Virus Coinfection and Superinfection

Open access
Atrial fibrillation: A review of modifiable risk factors and preventive strategies

REFERENCES 1. KIRCHHOF P, BREITHARDT G, BAX J, BENNINGER G, BLOMSTROM-LUNDQVIST C, BORIANI G et al. A roadmap to improve the quality of atrial fibrillation management: Proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference. Europace: European pacing, arrhythmias, and cardiac electrophysiology . Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2016; 18 (1):37-50. doi:10.1093/europace/euv304. 2. HONG KL

Open access
Impact of troponin I on outcome of ischemic stroke patients

REFERENCES 1. NICHOLS M, TOWNSEND N, SCARBOROUGH P, RAYNER M. Cardiovascular disease in Europe 2014: epidemiological update . Eur Heart J 2014; 35 :2929. 2. LLOYD-JONES D, ADAMS RJ, BROWN TM et al . Heart disease and stroke statistics--2010 update: a report from the American Heart Association . Circulation 2010; 121 :e46-e215. 3. BUDINCEVIC H, TIU C, BERECZKI D et al . Management of ischemic stroke in Central and Eastern Europe . Int J Stroke 2015; 10 Suppl A100:125-127. 4. ALPERT JS, MALASKY BR, THYGESEN K. Redefining myocardial

Open access
Cardiovascular risk factors in a Roma sample population from Romania

examination of Roma health insurance status in Central and Eastern Europe , Eur. J. Public Health. 2014; 24 (5):707-712. doi:10.1093/eurpub/cku004. 20. A.L. CATAPANO, I. GRAHAM, G. DE BACKER, OLOVWIKLUND, M.J. CHAPMAN, H. DREXEL, et al ., 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias , Eur. Heart J. 2016; 37 (39):2999-3058. doi:10.1093/eurheartj/ehw272. 21. B. VOZAROVA DE COURTEN, M. DE COURTEN, R.L. HANSON, A. ZAHORAKOVA, H.P. EGYENES, P.A. TATARANNI, et al ., Higher prevalence of type 2 diabetes, metabolic syndrome and cardiovascular

Open access
The Cardiovascular Risk in Cushing’s Syndrome

, M. Toth, C.J. Strasburger, P. Chanson, The European Registry on Cushing’s syndrome: 2-year experience. Baseline demographic and clinical characteristics, Eur J Endocrinol, 165 (2011), pp. 383-392. 5. A. Colao, R. Pivonello, S. Spiezia, A. Faggiano, D. Ferone, M. Filippella, Persistence of increased cardiovascular risk in patients with Cushing’s disease after five years of successful cure, J Clin Endocrinol Metab, 84 (1999), pp. 2664-2672. 6. Y. Liu, Y. Nakagawa, Y. Wang, R. Li, X. Li, T. Ohzeki, Leptin activation of corticosterone production in

Open access
Dual X-ray absorptiometry whole body composition of adipose tissue in rheumatoid arthritis

. ELKAN AC, ENGVALL IL, CEDERHOLM T, HAFSTROM I. Rheumatoid cachexia, central obesity and malnutrition in patients with low-active rheumatoid arthritis: feasibility of anthropometry, Mini Nutritional Assessment and body composition techniques . Eur J Nutr 2009; 48 : 315-322. 8. BILECIK NA, TUNA S, SAMANCI N, BALCI N, AKBAS H. Prevalence of metabolic syndrome in women with rheumatoid arthritis and effective factors . Int J ClinExp Med 2014; 7 : 2258-2265. 9. DA C, V, BRENOL CV, BRENOL JC, FUCHS SC, ARLINDO EM, MELO IM et al. Metabolic syndrome prevalence

Open access